Table 3.
Group | Characteristic |
3-year OS |
3-year DFS |
||||
Cutoff point | AUC | 95%CI | Cutoff point | AUC | 95%CI | ||
ES | NLR | 19.3 | 0.582 | 0.446-0.718 | 19.3 | 0.565 | 0.407-0.723 |
dNLR | 2.02 | 0.679 | 0.551-0.808 | 1.57 | 0.696 | 0.554-0.837 | |
PLR | 155 | 0.550 | 0.414-0.686 | 317 | 0.549 | 0.392-0.707 | |
SII | 3645 | 0.587 | 0.454-0.721 | 3645 | 0.564 | 0.403-0.726 | |
CEA | 6.7 | 0.591 | 0.458-0.724 | 11.2 | 0.604 | 0.442-0.766 | |
BTS | LMR | 1.67 | 0.611 | 0.424-0.798 | 1.67 | 0.571 | 0.366-0.776 |
CEA | 7.6 | 0.549 | 0.350-0.747 | 5.5 | 0.552 | 0.348-0.756 |
SEMS: Self-expanding metal stents; BTS: Bridge to surgery; AUC: Area under the receiver operating characteristic curve; dNLR: Derived neutrophil-to-lymphocyte ratio; PLR: Platelet–to-lymphocyte ratio; SII: Systemic immune inflammation index; LMR: Lymphocyte-to-monocyte ratio; CEA: Carcino-embryonic antigen. P < 0.05 was considered statistically significant.